AstraZeneca e-mails show debate on Seroquel risks

(AP) -- Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm sales, plaintiff lawyers say.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news162041479.html">AstraZeneca e-mails show debate on Seroquel risks</a></p> <p>(AP) -- Marketing executives at British drugmaker AstraZeneca PLC for years blocked efforts by company scientists to raise concerns antipsychotic drug Seroquel caused weight gain and other problems, saying that would harm sales, plaintiff lawyers say.</p>